Treatment of Relapsing Remitting MS/Disease Modifying Therapies: Efficacy and Side Effects

Name: Treatment of Relapsing Remitting MS/Disease Modifying Therapies: Efficacy and Side Effects
Uploaded: 2020-01-17T00:00:00+00:00
Description: Benjamin Segal, MD, describes FDA-approved therapies for multiple sclerosis that have been proven to reduce the odds of a relapse, delay disability progression and limit new disease activity.

Benjamin Segal, MD, describes FDA-approved therapies for multiple sclerosis that have been proven to reduce the odds of a relapse, delay disability progression and limit new disease activity.

Related Presenters

Benjamin Segal, MD

Neurology
Professor and Chair of the Department of Neurology

View full profile

Neurology and Neurosurgery

Treatment of Relapsing Remitting MS/Disease Modifying Therapies: Efficacy and Side Effects